Low P A, Ahlskog J E, Petersen R C, Waring S C, Esteban-Santillan C, Kurland L T
Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Neurology. 1997 Oct;49(4):1031-4. doi: 10.1212/wnl.49.4.1031.
Autonomic impairment is minor in idiopathic amyotrophic lateral sclerosis (ALS) and Alzheimer's-type dementia (D) and is usually not marked in Parkinson's disease. The autonomic status of Guamanian parkinsonism (P), ALS, and parkinsonism-dementia complex (PDC) is essentially unknown. We therefore evaluated the autonomic nervous system in Guamanian D, ALS, P, and PDC. Cardiovagal, adrenergic, and postganglionic sudomotor functions were quantitated in 16 patients and 14 paired household controls. Patients comprised PDC (N = 11), D (N = 2), P (N = 2), and ALS (N = 1). Autonomic deficit was expressed on a composite autonomic scoring scale (CASS) and its subsets that corrects for the effects of age and gender. CASS severity was rated from 0 to 10 and the maximal subset scores were 3, 3, and 4 for postganglionic sudomotor, cardiovagal, and adrenergic deficits, respectively. CASS scores for mild, moderate, and severe autonomic failure are 1 to 3, 4 to 6, and 7 to 10, respectively. Symptoms were scored by an Autonomic Symptom Profile (ASP). The affected patients were older than and had a sex distribution different from paired controls (64.2 +/- 8.0 versus 53.1 +/- 13.5; p < 0.01; male/female = 9/7 versus 2/12; p = 0.045). CASS scores were markedly increased over paired controls (6.2 +/- 2.3 versus 1.9 +/- 1.3; p < 0.001), and involvement was generalized by system. There were deficits in sudomotor, cardiovagal, and adrenergic function. Orthostatic hypotension occurred in 6 of 16 patients and 2 of 14 paired controls. Guamanian patients had more autonomic dysfunction than non-Guamanian Parkinson's disease. ASP scores were higher in patients than controls and regressed with CASS. These differences persisted when corrected for the confounding effects of age, gender, and diabetes. We conclude that Guamanian patients have autonomic failure to a greater extent than non-Guamanian Parkinson's disease or ALS. This autonomic failure suggests multisystem autonomic involvement similar to but less severe than in multiple system atrophy.
自主神经功能障碍在特发性肌萎缩侧索硬化症(ALS)和阿尔茨海默型痴呆(D)中较轻,在帕金森病中通常不明显。关岛帕金森综合征(P)、ALS和帕金森病痴呆综合征(PDC)的自主神经状态基本未知。因此,我们评估了关岛D、ALS、P和PDC患者的自主神经系统。对16例患者和14名配对的家庭对照者进行了心迷走神经、肾上腺素能和节后汗腺运动功能的定量检测。患者包括PDC(N = 11)、D(N = 2)、P(N = 2)和ALS(N = 1)。自主神经功能缺陷通过综合自主神经评分量表(CASS)及其校正年龄和性别影响的亚组进行评估。CASS严重程度从0到10评分,节后汗腺运动、心迷走神经和肾上腺素能功能缺陷的最大亚组评分分别为3、3和4。轻度、中度和重度自主神经功能衰竭的CASS评分分别为1至3、4至6和7至10。症状通过自主神经症状量表(ASP)进行评分。患病患者比配对对照者年龄更大,性别分布也不同(64.2±8.0岁对53.1±13.5岁;p<0.01;男/女=9/7对2/12;p = 0.045)。CASS评分比配对对照者显著升高(6.2±2.3对1.9±1.3;p<0.001),且按系统普遍受累。汗腺运动、心迷走神经和肾上腺素能功能均有缺陷。16例患者中有6例出现直立性低血压,14名配对对照者中有2例出现。关岛患者比非关岛帕金森病患者有更多的自主神经功能障碍。患者的ASP评分高于对照者,并与CASS评分呈负相关。在校正年龄、性别和糖尿病的混杂影响后,这些差异仍然存在。我们得出结论,关岛患者的自主神经功能衰竭程度比非关岛帕金森病或ALS患者更严重。这种自主神经功能衰竭提示多系统自主神经受累,与多系统萎缩相似但程度较轻。